The Wall Street Journal
@WSJ
Sign up for our newsletters and alerts: | Got a tip? | For WSJ customer support:
가입 April 2007
1.1K 팔로잉 중 22.3M 팬
Blackstone Life Sciences agreed to pay up to $1.5 billion to help Pfizer develop a GLP-1 receptor called berobenatide, an investigational drug being studied for chronic weight management and obesity-related conditions.
더 보기
